BSE filing, BSE: 541703. Summary written from the filing by ALFA Finder's alert engine.
Raconteur Global Resources Ltd: key numbers
- Share price
- ₹9.66
- Market cap
- ₹17.41 Cr
- Revenue (annual)
- ₹3.72 Cr
- Net profit (annual)
- ₹-21.34 Cr
- P/E (TTM)
- -0.8×Sector 27.9×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Raconteur Global Resources Ltd
All →Raconteur Global Resources Other Announcement
Raconteur Global Resources Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Raconteur Global Resources Capital Structure Change
Raconteur Global Resources Ltd received BSE trading approval for 24,99,999 equity shares issued at Rs. 14 per share, following the conversion of warrants.
- Value
- ₹3.50 Cr
Raconteur Global Resources Capital Structure Change
Max-Bio Biosciences acquired 21,42,857 shares (11.89% stake) in Raconteur Global Resources via preferential allotment. The non-promoter acquirer held no prior stake in the company.
Raconteur Global Resources Management Change
Raconteur Global Resources has appointed A S Bhutani & Associates as Statutory Auditor and Sourabh Parnami and Arvinder Singh Kohli as Non-Executive Independent Directors.
Raconteur Global Resources Annual General Meeting
Raconteur Global Resources held its 8th Annual General Meeting on 18th September, 2026. The meeting covered financial adoption, appointments, and preferential issue resolutions.
Raconteur Global Resources Annual General Meeting
Raconteur Global Resources issued a corrigendum to its 8th AGM notice, clarifying details on Resolution 7 & 8 regarding a proposed ₹30 Crore preferential issue.
- Value
- ₹30.00 Cr
Other capital structure change announcements
All →Apar Industries Capital Structure Change
APAR Industries will infuse up to USD 100 million in cash into wholly owned subsidiary PSPL during FY2026-27. The infusion is valued at Rs.952.40 Crore.
- Value
- ₹952.4 Cr
- Execution
- FY 2026-27, in single or multiple tranches
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 54,455 equity shares via Emkay Global on October 29, 2026 at an average of ₹263.76. Cumulative buyback stands at 24,10,906 shares under the ongoing open-market programme.
- Value
- ₹1.44 Cr
63 Moons Technologies Capital Structure Change
63SATS, a subsidiary of 63 Moons, signed a warrant subscription deal with BCCL. BCCL pays Rs 6.5 Crore upfront, deferring dilution until warrant exercise.
- Value
- ₹6.50 Cr
63 Moons Technologies Capital Structure Change
Material subsidiary 63SATS Cybertech signed a warrant subscription agreement with Bennett Coleman for 65 warrants. Aggregate warrant value is Rs.65 Crore, with 10% (Rs.6.5 Crore) payable upfront.
- Value
- ₹65.00 Cr
Otco International Capital Structure Change
OTCO International Ltd fixed 06 November 2026 as the record date for consolidating 5 equity shares of Rs.2 face value into 1 share of Rs.10 face value. The consolidation was approved by shareholders at the AGM held 17 September 2026.
Meesho Capital Structure Change
Meesho will invest up to USD 1 lakh in cash, in tranches, in its wholly owned US subsidiary. Its 100% holding stays unchanged, worth about ₹0.01 Crore.
- Value
- ₹0.01 Cr